Southern Shuanglin Bio-Pharmacy announces 2024 profit distribution

Southern Shuanglin Bio-Pharmacy (SZSE:000403) announced its 2024 profit distribution plan, approved at the shareholder meeting on May 21, 2025. Shareholders will receive a cash dividend of CNY3.50 per 10 shares. This represents 34.33% of the net profit attributable to shareholders for 2024. Additionally, the company will increase share capital by transferring 3 shares for every 10 shares from capital reserve. The equity registration date is set for June 3, 2025, and the ex-right and ex-dividend date is June 4, 2025. The total number of shares after the transfer will increase to 950,397,386. The company will distribute cash dividends to A-share shareholders through China Securities Depository and Clearing Corporation Shenzhen Branch (CSDCC).